Proteome Sciences plc (LON:PRM – Get Free Report) shares crossed above its 200-day moving average during trading on Tuesday. The stock has a 200-day moving average of GBX 1.63 and traded as high as GBX 1.69. Proteome Sciences shares last traded at GBX 1.69, with a volume of 16,930 shares trading hands.
Proteome Sciences Price Performance
The company has a market cap of £3.86 million, a P/E ratio of -1.53 and a beta of 0.16. The company has a debt-to-equity ratio of -161.07, a quick ratio of 0.37 and a current ratio of 0.12. The firm’s fifty day moving average is GBX 1.44 and its two-hundred day moving average is GBX 1.61.
Proteome Sciences (LON:PRM – Get Free Report) last posted its quarterly earnings results on Wednesday, September 16th. The company reported GBX (0.41) EPS for the quarter. Proteome Sciences had a negative net margin of 61.46% and a positive return on equity of 23.85%.
Proteome Sciences Company Profile
Proteome Sciences plc provides contract research services for the identification, validation, and application of protein biomarkers in the United States, the United Kingdom, European Union, and internationally. The company offers TMT LC-MS2, a standard method for analyzing cells and tissues when no phosphopeptide enrichment is required; TMT LC-MS3, a standard method for biomarker discovery in plasma and other samples where quantitative accuracy is a factor; SysQuant, provides an analysis of protein activity across regulatory and signaling pathways; and TMTcalibrator, analyzes where diseased or treated tissue can be analyzed in parallel with peripheral fluids.
Further Reading
- Five stocks we like better than Proteome Sciences
- Checkmate for AI Chips? NVIDIA’s Crisis Opens the Board
- Can NVIDIA Maintain Its Momentum Without Huang?
- Six Flags Lost $366 Million in Q3—Its Insiders Just Went Shopping
- What Went Wrong With Amprius Technologies’ Q3? Less Than You’d Think
Receive News & Ratings for Proteome Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Proteome Sciences and related companies with MarketBeat.com's FREE daily email newsletter.
